Latest STERIS News & Updates

See the latest news and media coverage for STERIS. We track all announcements, press releases, and industry mentions in real time, all in one place.

STERIS

Infection prevention products and services provider

steris.com

Headquarters: Mentor, United States
Founded year: 1985
Company type: Public company
Number of employees: 10,000+
Industry: Medical Equipment, Supplies & Distribution

Last updated Today

Latest news about STERIS

In short: STERIS reported record fiscal year 2026 results with $10.17 adjusted EPS, initiated a $1 billion buyback, and appointed a new CFO.

Company announcements

July 30 STERIS

STERIS raises dividend to $0.69 per share

The quarterly interim dividend increase of $0.06 marks the 21st consecutive year of growth.

May 11 STERIS

STERIS reports fiscal 2026 Q4 and full year results

Revenue increased 9% and adjusted EPS rose to $10.17, with a new $1 billion share repurchase program.

May 7 STERIS

STERIS appoints Pierre Boulud to Board of Directors

Effective May 5, 2026, Boulud, CEO of bioMérieux, joins with extensive leadership experience in diagnostics and biotech.

February 4 STERIS

STERIS announces fiscal 2026 third quarter financial results

Total revenue increases 9% to $1.5 billion. Adjusted EPS rises to $2.53. Fiscal 2026 outlook maintained.

Media coverage

July 30 Seeking Alpha

Steris raises quarterly dividend by 9.5% to $0.69/share (NYSE:STE)

Steris (STE) raises quarterly dividend to $0.69/share (+9.5%) with 1.19% forward yield.

July 28 GuruFocus

STE Initiated Coverage by UBS -- Price Target Set at $275

On October 03, 2023, UBS initiated coverage on Steris (STE) with a rating of 'Buy'. The new price...

July 28 Yahoo Finance

STERIS' Q1 Earnings on Deck: What's in Store for the Stock?

STE is expected to deliver fiscal first-quarter revenue and EPS growth, driven by strength in Healthcare, continued momentum in AST, and healthy demand in Life...

July 7 Kalkine Media

STERIS (NYSE:STE) Sparks A Fresh Quality Debate

STERIS faces fresh valuation debate as healthcare services, infection prevention demand, margins, and recurring revenue remain in focus.

Never miss news about STERIS

Track STERIS and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

STERIS competitors & trending companies

Browse news for competitors to STERIS and other trending companies.